Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)

NCT06385821 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT06385821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06385821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)
Lead sponsor
NPO Petrovax
Phase
Phase 3
Overall status
Completed
Start date
September 21, 2022
Completion date
October 9, 2023
Enrollment
824 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, flu, flu, human, influenza, influenza a, influenza a h1n1, influenza a h3n2, influenza epidemic, influenza type b, influenza, human, vaccine reaction